BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

478 related articles for article (PubMed ID: 15198361)

  • 1. Overexpression of KIT (CD117) in chromophobe renal cell carcinoma and renal oncocytoma.
    Pan CC; Chen PC; Chiang H
    Am J Clin Pathol; 2004 Jun; 121(6):878-83. PubMed ID: 15198361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. C-kit expression in renal oncocytomas and chromophobe renal cell carcinomas.
    Huo L; Sugimura J; Tretiakova MS; Patton KT; Gupta R; Popov B; Laskin WB; Yeldandi A; Teh BT; Yang XJ
    Hum Pathol; 2005 Mar; 36(3):262-8. PubMed ID: 15791570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of vitamin D3 receptor in kidney tumors.
    Liu W; Tretiakova M; Kong J; Turkyilmaz M; Li YC; Krausz T
    Hum Pathol; 2006 Oct; 37(10):1268-78. PubMed ID: 16949927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of CD9/motility-related protein 1 (MRP-1) in renal parenchymal neoplasms: consistent expression in papillary and chromophobe renal cell carcinomas.
    Kuroda N; Inoue K; Guo L; Miyazaki E; Hayashi Y; Naruse K; Toi M; Hiroi M; Shuin T; Enzan H
    Hum Pathol; 2001 Oct; 32(10):1071-7. PubMed ID: 11679941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of kidney-specific cadherin in chromophobe renal cell carcinoma and renal oncocytoma.
    Adley BP; Gupta A; Lin F; Luan C; Teh BT; Yang XJ
    Am J Clin Pathol; 2006 Jul; 126(1):79-85. PubMed ID: 16753598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of KIT (CD117) in renal cell carcinoma and renal oncocytoma.
    Krüger S; Sotlar K; Kausch I; Horny HP
    Oncology; 2005; 68(2-3):269-75. PubMed ID: 16015044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression analysis of kidney-specific cadherin in a wide spectrum of traditional and newly recognized renal epithelial neoplasms: diagnostic and histogenetic implications.
    Kuehn A; Paner GP; Skinnider BF; Cohen C; Datta MW; Young AN; Srigley JR; Amin MB
    Am J Surg Pathol; 2007 Oct; 31(10):1528-33. PubMed ID: 17895753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chromophobe renal cell carcinoma: an immunohistochemical study of 21 Japanese cases.
    Taki A; Nakatani Y; Misugi K; Yao M; Nagashima Y
    Mod Pathol; 1999 Mar; 12(3):310-7. PubMed ID: 10102617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The MIB-1 tumor proliferation index in adult renal epithelial tumors with granular cytoplasm: biologic implications and differential diagnostic potential.
    Tickoo SK; Amin MB; Linden MD; Zarbo RJ
    Mod Pathol; 1998 Nov; 11(11):1115-21. PubMed ID: 9831210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. C-kit overexpression is not associated with KIT gene mutations in chromophobe renal cell carcinoma or renal oncocytoma.
    Zimpfer A; Janke S; Hühns M; Schneider B; Kundt G; Zettl H; Kilic E; Maruschke M; Hakenberg OW; Erbersdobler A
    Pathol Res Pract; 2014 Aug; 210(8):521-5. PubMed ID: 24875296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. S100A1 and KIT gene expressions in common subtypes of renal tumours.
    Li G; Gentil-Perret A; Lambert C; Genin C; Tostain J
    Eur J Surg Oncol; 2005 Apr; 31(3):299-303. PubMed ID: 15780567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. S100A1: a powerful marker to differentiate chromophobe renal cell carcinoma from renal oncocytoma.
    Li G; Barthelemy A; Feng G; Gentil-Perret A; Peoc'h M; Genin C; Tostain J
    Histopathology; 2007 Apr; 50(5):642-7. PubMed ID: 17394501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The diagnostic utility of MOC31, BerEP4, RCC marker and CD10 in the classification of renal cell carcinoma and renal oncocytoma: an immunohistochemical analysis of 328 cases.
    Pan CC; Chen PC; Ho DM
    Histopathology; 2004 Nov; 45(5):452-9. PubMed ID: 15500648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. KIT expression in normal and neoplastic renal tissues: immunohistochemical and molecular genetic analysis.
    Kato N; Honma K; Hojo H; Sasou S; Matsuzaki O; Motoyama T
    Pathol Int; 2005 Aug; 55(8):479-83. PubMed ID: 15998375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of the glucocorticoid receptor in renal cell neoplasms: an immunohistochemical and quantitative reverse transcriptase polymerase chain reaction study.
    Yakirevich E; Matoso A; Sabo E; Wang LJ; Tavares R; Meitner P; Morris DJ; Pareek G; Delellis RA; Resnick MB
    Hum Pathol; 2011 Nov; 42(11):1684-92. PubMed ID: 21531004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential expression of KAI1 metastasis suppressor protein in renal cell tumor histological subtypes.
    Kauffman EC; Barocas DA; Chen YT; Yang XJ; Scherr DS; Tu JJ
    J Urol; 2009 May; 181(5):2305-11. PubMed ID: 19303095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inactivation of BHD in sporadic renal tumors.
    Khoo SK; Kahnoski K; Sugimura J; Petillo D; Chen J; Shockley K; Ludlow J; Knapp R; Giraud S; Richard S; Nordenskjöld M; Teh BT
    Cancer Res; 2003 Aug; 63(15):4583-7. PubMed ID: 12907635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alpha-methyl CoA racemase expression in renal cell carcinomas.
    Molinié V; Balaton A; Rotman S; Mansouri D; De Pinieux I; Homsi T; Guillou L
    Hum Pathol; 2006 Jun; 37(6):698-703. PubMed ID: 16733210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microsatellite allelotyping differentiates chromophobe renal cell carcinomas from renal oncocytomas and identifies new genetic changes.
    Nagy A; Buzogany I; Kovacs G
    Histopathology; 2004 Jun; 44(6):542-6. PubMed ID: 15186268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kit (CD117) immunoreactivity is rare in renal cell and upper urinary tract transitional cell carcinomas.
    Zigeuner R; Ratschek M; Langner C
    BJU Int; 2005 Feb; 95(3):315-8. PubMed ID: 15679785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.